Telexos


Telexos

Telexos was founded as a technology buyout from Roche Diagnostics. We are dedicated to the analysis of Circulating Tumor Cells (CTCs) in patients'​ biological fluids (liquid biopsy). The heart of the technology is a patented sample preparation procedure which avoids any loss of the precious CTCs. This procedure will be combined with a unique single cell deposition system to enable detailed personalized cancer diagnostics.

https://www.telexos.de/